Asia Pacific Lancet Pen Needels Market Summary
The Asia-Pacific Lancet and Pen Needles market is projected to grow significantly from 1.95 USD Billion in 2024 to 4.93 USD Billion by 2035.
Key Market Trends & Highlights
Asia Pacific Lancet and Pen Needles Key Trends and Highlights
- The market is expected to expand at a compound annual growth rate (CAGR) of 8.81% from 2025 to 2035.
- By 2035, the market value is anticipated to reach 4.93 USD Billion, indicating robust growth potential.
- In 2024, the market is valued at 1.95 USD Billion, laying a strong foundation for future expansion.
- Growing adoption of advanced pen needle technology due to increasing prevalence of diabetes is a major market driver.
Market Size & Forecast
2024 Market Size | 1.95 (USD Billion) |
2035 Market Size | 4.93 (USD Billion) |
CAGR (2025-2035) | 8.81% |
Major Players
BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe)